Rosetta Genomics, Ltd. (NASDAQ: ROSG) announced today that starting April 1, 2010 physicians are able to send FNA cell block ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE